VeriMomБезопасен ли quercetagetin при беременности?
No EU cosmetic regulatory restriction or ban (Annex II/III) or harmonised CLP (ECHA Annex VI) classification was found for quercetagetin (CAS 90-18-6), and a search of available safety-assessment repositories (CIR/SCCS) returned no specific cosmetic safety opinion for this exact substance. PubChem lists the compound (CID 5281680) but there are no clear animal developmental/reproductive toxicity studies for topical exposure to quercetagetin in the peer‑reviewed literature—therefore default hazard (h=0), mechanism (m=0) and exposure (e=0) scores apply for pregnancy. (See PubChem entry and EU cosmetics/COSING and ECHA pages showing no specific restrictions or harmonised classification.)
Related ingredients
Frequently asked questions
- Безопасен ли quercetagetin при беременности?
- No EU cosmetic regulatory restriction or ban (Annex II/III) or harmonised CLP (ECHA Annex VI) classification was found for quercetagetin (CAS 90-18-6), and a search of available safety-assessment repositories (CIR/SCCS) returned no specific cosmetic safety opinion for this exact substance. PubChem lists the compound (CID 5281680) but there are no clear animal developmental/reproductive toxicity studies for topical exposure to quercetagetin in the peer‑reviewed literature—therefore default hazard (h=0), mechanism (m=0) and exposure (e=0) scores apply for pregnancy. (See PubChem entry and EU cosmetics/COSING and ECHA pages showing no specific restrictions or harmonised classification.)
- Безопасен ли quercetagetin при грудном вскармливании?
- No data specific to lactation or transfer into breast milk for quercetagetin was identified in regulatory or peer‑reviewed sources; no harmonised CLP or EU cosmetic restriction applies. In the absence of substance‑specific reproductive/lactation data, and given the lack of evidence of systemic reproductive hazard for this specific flavonoid, default scores are used (h=0, m=0, e=0).
- Безопасен ли quercetagetin для кожи малыша?
- No baby/infant (0–3 yr) topical safety data were identified for quercetagetin and no regulatory infant-specific restriction exists. Per the scoring rules, because there is measurable/possible dermal absorption for many small polyphenolic flavonoids (and no specific evidence showing zero absorption), exposure for baby skin is increased by +1 versus adult (adult e=0 → baby e=1) while hazard and mechanism remain default (h=0, m=0) absent infant-specific adverse data or harmonised classification.
- Как VeriMom оценивает quercetagetin?
- VeriMom оценивает quercetagetin в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы quercetagetin при беременности?
- См. наш список безопасных альтернатив quercetagetin с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.